País: Irlanda
Idioma: anglès
Font: HPRA (Health Products Regulatory Authority)
NIFEDIPINE
Rowex Ltd
NIFEDIPINE
20 Milligram
Modified-release Tablets
Product subject to prescription which may be renewed (B)
Authorised
0000-00-00
PACKAGE LEAFLET: INFORMATION FOR THE USER NIFED RETARD 20 MG MODIFIED RELEASE TABLETS Active substance: nifedipine READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE, BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you. Do not pass it on to others. It may harm them even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. WHAT IS IN THIS LEAFLET: 1. What Nifed Retard is and what it is used for 2. What you need to know before you take Nifed Retard 3. How to take Nifed Retard 4. Possible side effects 5. How to store Nifed Retard 6. Contents of the pack and other information. Nifed Retard contains nifedipine which belongs to a group of medicines called calcium antagonists. Nifed Retard is used to treat: • Mild to moderate high blood pressure • A certain type of chest pain called angina pectoris If you suffer from high blood pressure Nifed Retard works by relaxing blood vessels, so that blood passes through them more easily. If you suffer from angina Nifed Retard works by improving blood supply to the heart muscle which then receives more oxygen and as a result chest pain is prevented. Nifedipine does not provide immediate relief of chest pain from angina. 1 WHAT NIFED RETARD IS AND WHAT IT IS USED FOR 2 WHAT YOU NEED TO KNOW BEFORE YOU TAKE NIFED RETARD DO NOT TAKE NIFED RETARD if you have any of the following conditions: • allergy to nifedipine (active substance) or to any of the ingredients (listed in section 6). • allerg Llegiu el document complet
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Nifed Retard 20 mg modified-release Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each modified release tablet contains Nifedipine 20 mg. Excipients: contains lactose monohydrate 9.8mg For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Modified-release film-coated tablet Round, pink to light red biconvex tablet. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the treatment of mild to moderate hypertension and for the management of chronic stable angina pectoris. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION 4.2 POSOLOGY AND METHOD OF ADMINISTRATION ROUTE OF ADMINISTRATION: Oral. Dosage regimen As far as possible the treatment must be tailored to the needs of the individual according to the severity of the disease and the patient’s response. Depending on the clinical picture in each case, the basic dose must be introduced gradually. Nifed retard 10mg is particularly suitable for dose titration. Dose titration is particularly recommended for hypertensives with severe cerebrovascular disease and for patients, who because of low body weight or multiple therapies with other antihypertensive drugs, are likely to have an excessive reaction to nifedipine. In addition, patients in whom side effects in response to the nifedipine treatment make a finer dose adjustment desirable should be individually stabilised with Nifed retard 10mg. Unless otherwise prescribed, the following dosage guidelines apply for adults: • In coronary heart disease: Chronic stable angina pectoris 1 Nifed retard 10mg tablet twice daily (angina of effort) (2 x 10 mg/day) 1 Nifed retard 20mg tablet twice daily (2 x 20 mg/day) If higher dosages are necessary, the dose can be increased in stages up to a maximum 60mg daily. IRI Llegiu el document complet